A clinician is choosing between Depo Provera and combined oral contraceptives for a patient with migraine wit… - RRB Nsg. Superintendent-2026 (Shift -2nd)

RRB Nsg. Superintendent-2026 (Shift -2nd)

Pharmacology

Medium

Appeared in: RRB Nsg. Superintendent-2026 (Shift -2nd)

Explanation

Depo-Provera is a progestin-only contraceptive, meaning it is completely free of estrogen.
Combined oral contraceptives (COCs) contain estrogen, which is strictly contraindicated in patients who experience migraines with aura.
The use of estrogen in this patient population significantly increases the risk of ischemic stroke.
By lacking estrogen, Depo-Provera avoids this dangerous risk, making it the preferred and safer contraceptive choice.

Option A: Depo-Provera is a synthetic form of the hormone progestin, not an androgen. The primary concern and reason for the choice is to decrease, not increase, stroke risk.
Option B: Depo-Provera contains no estrogen. Additionally, high estrogen levels are dangerous and contraindicated for patients with migraine with aura; they do not reduce migraines in this context.
Option C: This statement describes the problem with combined oral contraceptives, not the reason for preferring Depo-Provera. The key advantage of Depo-Provera is its absence of estrogen.

Visual 1: Comparison Table - A table contrasting Depo-Provera and Combined Oral Contraceptives, highlighting their hormonal content (Progestin-only vs. Estrogen + Progestin) and their suitability for patients with migraine with aura.
Visual 2: Flowchart - A decision-making flowchart for selecting hormonal contraception, showing the pathway where a history of 'migraine with aura' leads to the avoidance of all estrogen-containing methods.

Clinical Relevance

Nursing practice connection: Use the key finding related to Hormonal contraception selection in patients with contraindications, specifically migraine with aura to guide bedside assessment, documentation, and the next nursing action.
A thorough patient medical history is one of the most critical nursing responsibilities before any hormonal contraceptive is prescribed. This includes screening for migraine with aura, a history of blood clots (VTE), uncontrolled hypertension, and smoking status in women over 35.
Patient education is paramount. Nurses must teach patients the specific risks of their prescribed contraceptive and the warning signs of serious complications. For COCs, the 'ACHES' acronym (Abdominal pain, Chest pain, Headaches, Eye problems, Severe leg pain) is a vital tool.
What if the patient had migraines without an aura? In this scenario, the risk is lower, and a low-dose combined hormonal contraceptive might be considered a Category 2 by the WHO (advantages generally outweigh risks). However, progestin-only methods like Depo-Provera are still often preferred as an even safer option.

How to Approach the Question

First, identify the core clinical scenario: choosing a contraceptive for a patient with a specific medical condition.
Recognize the key patient factor provided in the stem: 'migraine with aura'.
Recall the absolute contraindication associated with this condition: the use of estrogen-containing contraceptives due to a significantly increased risk of ischemic stroke.
Analyze the contraceptive options. Depo-Provera is a well-known progestin-only method. Combined oral contraceptives, by definition, contain both estrogen and progestin.
Evaluate each option based on this knowledge. The option stating that Depo-Provera lacks estrogen and thus reduces stroke risk directly addresses the clinical reasoning for this choice.
Eliminate the other options. Option A is incorrect about the hormone type. Option B is incorrect about the hormone content and its effect. Option C correctly identifies the risk of the other drug class (COCs) but doesn't explain the benefit of Depo-Provera.

Concept Tested & Keywords

Concept Tested: Hormonal contraception selection in patients with contraindications, specifically migraine with aura.
Stem keywords: Depo Provera, combined oral contraceptives, migraine with aura
Lead-in keywords: Why, preferred
Clinical cues: Patient condition 'migraine with aura' is a critical cue indicating a contraindication for estrogen.
Negative lead-in flag: false

Q5RliyMS5pe1MudSQhFJFt